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Enabling axon regeneration after central nervous system (CNS) injury remains a major challenge in neurobi-
ology. One of the major differences between the injured peripheral nervous system (PNS) and CNS is the
pro- and antiregenerative responses of their glial cell populations. In addition to intrinsic qualities of the neu-
rons themselves, glial-driven changes to the neural environment have a significant impact on regenerative
outcome. This Review presents a comparison of the glial response to injury between the CNS and PNS
and highlights features of the PNS glial response that, with continued study, might reveal long-sought-after
keys to achieving CNS repair.Introduction
Why Don’t CNS Axons Regenerate?
In higher vertebrates, peripheral nervous system (PNS) axons
regenerate after injury while central nervous system (CNS) axons
do not. This striking contrast in regenerative capacity is due
to differences in the intrinsic properties of injured CNS and
PNS neurons, as well as to differences in the CNS and PNS en-
vironments. Two major phenomena illustrate the contribution of
intrinsic factors to CNS axon regeneration failure. First, mamma-
lian CNS neurons regenerate their axons significantly faster dur-
ing a perinatal window than just days or weeks later (Shimizu
et al., 1990; Liu et al., 2011). Although this decrease in axon
outgrowth capacity coincides temporally with the maturation of
glial cells and the onset of myelination, this phenomenon persists
when neurons are purified away from other CNS cell types and
when myelin is depleted (Chen et al., 1995; Goldberg et al.,
2002; Bouslama-Oueghlani et al., 2003), indicating an intrinsic
switch in axon outgrowth ability. Second, prior peripheral axot-
omy of dorsal root ganglia (DRG) neurons greatly enhances the
regenerative capacity of the neurons’ central processes upon
subsequent CNS lesion. This enhanced regenerative capacity
occurs in the absence of any changes to the central axon’s extra-
cellular environment (Neumann and Woolf, 1999). These two
observations have fueled the discovery in recent years of key
growth-associated molecules, signaling pathways, and tran-
scription factors that modulate a neuron’s intrinsic capacity for
axon growth, including GAP-43, cAMP, PTEN, mTOR, KLF4,
and SOCS3. For a more complete discussion of intrinsic factors
in CNS regeneration, readers are referred to excellent recent
reviews of this topic (Liu et al., 2011; Sun and He, 2010).
The stage for the discovery of specific environmental cues that
influence axon regeneration was set by experiments conducted
by David and Aguayo demonstrating that (1) peripheral neurons
capable of regenerating over long distances in the PNS lose their
ability to do so within the environment of a CNS nerve graft and,
conversely, (2) the ability of numerous CNS neurons to regen-
erate is vastly enhanced within bridges of peripheral nerve tissue
(Aguayo et al., 1981). Since these landmark studies, much
progress has been made toward understanding the molecular
basis for these observations. Several major components of theextracellular environment are now recognized to play important
roles in axon regeneration. These extrinsic factors include extra-
cellular matrix molecules, trophic factors, chemorepulsive guid-
ance cues, and myelin-associated proteins and lipids.
The composition of the CNS and PNS extracellular milieu is
highly influenced by a class of nonneural, neurectoderm-derived
cells known as glia. These cells, neuroepithelium-derived oligo-
dendrocytes and astrocytes in the CNS and neural crest-derived
Schwann cells in the PNS, outnumber their neural neighbors in
humans and play key roles in creating both the growth-promot-
ing environment of the injured PNS and the growth-inhibitory
environment of the injured CNS (Allen and Barres, 2009). The
present Review focuses on the role of glia in nerve regeneration
and aims to compare and contrast the contribution of CNS and
PNS glia to five key elements of axon regeneration: neuronal sur-
vival, extracellular matrix composition, production and clearance
of inhibitory myelin-associated proteins and lipids, and modula-
tion of the inflammatory milieu.
What Does It Take to Get an Axon Growing?
Although often referred to as distinct components of the axon
growth equation, intrinsic and extrinsic growth cues are now
recognized to be highly interconnected. For example, one of
the direct consequences of intracellular cyclic AMP (cAMP)
elevation is increased cell-surface localization of TrkB neurotro-
phin receptors, resulting in heightened neuronal responsiveness
to extracellular neurotrophins (Meyer-Franke et al., 1998; Liu
et al., 2011). Similarly, we now know that a potent downstream
effect of axon interaction with extracellular myelin debris in-
volves intracellular activation of RhoA, rendering cytoskeletal
dynamics unfavorable for axon extension (Yiu and He, 2006). A
recent study by He and colleagues highlights the exciting thera-
peutic potential of targeting intrinsic factors. In this report, the
authors demonstrate extensive and sustained axon regeneration
in the optic nerve following concomitant deletion of genes PTEN
and SOCS3 (Sun et al., 2011). How manipulation of PTEN and
SOCS3 signaling interfaces with pathways downstream of
extrinsic inhibitory cues is an interesting ongoing area of study
(Park et al., 2010). It will also be interesting to see whether this
regenerative phenotype can be further enhanced if coupled
with strategies to dampen extrinsic inhibition. Indeed, asDevelopmental Cell 28, January 13, 2014 ª2014 Elsevier Inc. 7
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extracellular pro- and antiregenerative cues deepens, the ulti-
mate cellular consequences of extrinsic and intrinsic factors
converge on a list of neuronal properties that appear to be impor-
tant for axon regeneration. Key elements to date include the abil-
ity to retrogradely transport an injury signal to the cell soma, cell
survival, an increase in de novo protein synthesis, anterograde
transport of needed cellular constituents, favorable cytoskeletal
dynamics, heightened responsiveness to trophic support, and
downregulated responsiveness to inhibitory extracellular cues
(Liu et al., 2011). As we shall see, the glial response to axon injury
has a strong influence on several of these neuronal properties.
What Do Glia Do?
Astrocytes. Astrocytes are neuroepithelium-derived glia with
finely branched processes found throughout the CNS. In the
healthy CNS, astrocytes divide at a very low rate and provide
several activities essential for neuronal function: they produce
trophic support for neurons, perform homeostatic maintenance
of the extracellular ionic environment and pH, clear and poten-
tially release glutamate, provide metabolic substrates for neu-
rons, couple cerebral blood flow to neuronal activity, and play
a key role in synapse formation, maintenance, and function
(Sofroniew, 2005; Eroglu and Barres, 2010; Allen et al., 2012).
The mature astrocyte response to injury is a complex phenome-
non termed ‘‘reactive gliosis,’’ characterized by cellular hypertro-
phy, changes in gene expression, and cellular proliferation
following particularly severe insults (Sofroniew, 2005, 2009).
The specific stimuli that induce this response are still unknown,
but degenerating axons and their dying terminals, serum-derived
molecules at areas of blood-brain-barrier breakdown, and
inflammation-associated cytokines have all been suggested to
play an important role (Fitch and Silver, 2008). Elegant work
over the past few years has begun to elucidate the molecular un-
derpinnings of reactive gliosis and to examine its effects on
astrocyte function (Wanner et al., 2013; Zamanian et al., 2012;
Voskuhl et al., 2009; Faulkner et al., 2004; Bush et al., 1999).
Certain aspects of this process will be discussed in detail below.
Oligodendrocytes. Oligodendrocytes are also derived from
the neuroepithelium and are the myelinating glia of the CNS. In
humans, the period of myelination begins before birth and
continues in some brain regions until 25–30 years of age (Fields,
2008). Each oligodendrocyte extends processes that wrap
numerous neighboring axons, with some forming a myelin inter-
node on up to 50 axons. Although myelinating oligodendrocytes
are postmitotic, a slowly dividing population of oligodendrocyte
precursor cells (OPCs) persists in the adult brain (Kang et al.,
2010; Fancy et al., 2011). In addition, new OPCs are generated
from subventricular zone progenitors following injury (Fancy
et al., 2011).
Schwann Cells. One of the major differences between the CNS
and the PNS is the proportion of myelinated versus unmyelinated
fibers. In the CNS, nearly all white matter tracts are myelinated,
whereas in the PNS, there are approximately four times as
many unmyelinated axons as myelinated ones (Griffin and
Thompson, 2008). All PNS axons are ensheathed by neural-
crest-derived Schwann cells, which constitute over 80% of the
cells in the adult peripheral nerve. According to axonal cues,
these PNS glia differentiate during development into either non-
myelinating (Remak) Schwann cells or myelinating Schwann8 Developmental Cell 28, January 13, 2014 ª2014 Elsevier Inc.cells (Griffin and Thompson, 2008). In stark contrast to oligoden-
drocytes, myelinating Schwann cells form only one myelin inter-
node around a single axon. Remak cells typically ensheath
(without producing myelin) several axons, forming a Remak
bundle. Schwann cells undergo a remarkable transformation in
response to injury characterized by a transient period of prolifer-
ation and extensive changes in gene expression. Although many
of the molecular changes result in a cellular state reminiscent of
immature Schwann cells, recent work has determined the post-
injury Schwann cell to be a unique repair cell poised to aid PNS
regeneration with several features not found in earlier phases of
the Schwann cell lineage (Arthur-Farraj et al., 2012). Further-
more, these studies have identified c-jun activation and upregu-
lated Raf/Erk signaling as key regulators of the Schwann cell
transformation (Arthur-Farraj et al., 2012; Napoli et al., 2012).
As the mechanisms of the Schwann cell response to injury are
further elucidated, they may provide clues as to how to induce
astrocytes and/or oligodendrocytes in the CNS to play a more
productive role in nervous system repair.
Glial Survival and Support of Neuronal Survival after
Axon Injury
Do Glia Survive after Axon Injury?
A recurring theme during neural development is the use of a
limited supply of target-derived survival factors to match cell
numbers to their targets (Oppenheim, 1989). In the PNS, axon-
derived type III neuregulin dictates Schwann cell survival during
development, and in the current model of CNS development,
oligodendrocytes compete for axon-derived cues for their sur-
vival as well (Barres and Raff, 1999). If this scenario persisted
into adulthood, axon degeneration distal to an injury would
lead to widespread glial cell death. In the PNS, Schwann cell
maturation is accompanied by the establishment of autocrine
survival circuits involving PDGF, IGF-1, and NT3 (Jessen and
Mirsky, 1999). This mechanism ensures very little Schwann cell
death after axon injury, allowing Schwann cells to play an active
supportive role in PNS axon regeneration. However, following
periods of chronic denervation lasting several months or more,
increased Schwann cell death is ultimately observed (Ebenezer
et al., 2007).
Studies of oligodendrocyte loss in adult compared with young
rodents suggest that, like Schwann cells, dependence on axons
for survival decreaseswith age (Barres andRaff, 1999). Nonethe-
less, in stark contrast to the near-complete survival of Schwann
cells in the injured PNS, rates of oligodendrocyte loss as high as
30%–40% are observed following axon injury in the mature CNS
after months to years (Ludwin, 1990). In addition to some degree
of continued axon dependence, oligodendrocyte loss after CNS
injury is attributed to excitotoxicity, inflammatory cytokine
release bymicroglia and infiltrating neutrophils, and the exquisite
vulnerability of these cells to oxidative stress from ischemia
and reperfusion (Almad et al., 2011). Reported mechanisms of
oligodendrocyte death include apoptosis, necrosis, and, most
recently, autophagy (Almad et al., 2011). Surprisingly, the oligo-
dendrocytes that survive injury appear to be of little utility in
terms of CNS repair. These cells are described as inactive or
quiescent and do not contribute to remyelination of spared
axons (Ludwin, 1990; Blakemore and Keirstead, 1999). Instead,
oligodendrocyte precursor cells, either OPCs resident in the
Developmental Cell
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precursors, differentiate into oligodendrocytes and perform
successful remyelination (Blakemore and Keirstead, 1999;
Almad et al., 2011).
Astrocytes survive CNS injury, but the signals required for
their survival have long been mysterious. In recent work estab-
lishing a novel system for serum-free culture of mature astro-
cytes in vitro, Foo et al. found that endothelial cells, pericytes,
and astrocytes themselves could promote astrocyte survival in
culture. In addition, this work identified two molecules, heparin
binding epidermal growth factor (HbEGF) and Wnt7a, as astro-
cyte survival factors and demonstrated elevated expression of
HbEGF in brain endothelial cells. Based on these findings and
consistent association of astrocyte endfeet with blood vessels
in the mature brain, this study concludes that in addition to pro-
moting their own survival, astrocytes in the healthy brain likely
rely on vasculature-derived trophic support from endothelial
cells and pericytes (Foo et al., 2011). Whether these same
mechanisms act to keep astrocytes alive after injury has not
been confirmed.
How Do Glia Support Neuronal Survival?
Target-derived trophic support regulates neuronal survival
during development, but what about after injury? Recent work
presents evidence that a single transcription factor, dual leucine
zipper kinase (DLK), primes the injured neuron for two possible
responses to axon injury—apoptosis and regeneration—and
that the path to go down is determined by the abundance of
pro- or antiregenerative cues received by the neuron (Watkins
et al., 2013). In line with this data, trophic factors have known
effects on both neuronal survival and axon outgrowth. These
factors bind to transmembrane receptors, typically tyrosine
kinase receptors, and activate intracellular signaling pathways
that inhibit apoptosis machinery from carrying out cell suicide.
Two well-known pathways involved in trophic factor-mediated
survival are the PI3-kinase/Akt pathway and the ras/raf/MAP ki-
nase pathway (Goldberg and Barres, 2000). The PI3-kinase/Akt
pathway is upstream of GSK3-b and cytoskeletal arrangements
favoring axon extension, perhaps explaining the dual effect of
trophic support on neuronal survival and axon growth after injury
(Chen et al., 2007).
Much like Schwann cells, mature PNS neurons are believed to
decrease their dependence on target-derived trophic support
and establish autocrine circuits to promote their own survival
(Acheson et al., 1995). After injury, Schwann cells provide an
additional and important source of prosurvival factors for neu-
rons. Schwann cells in the injured nerve upregulate numerous
members of the neurotrophin family, including GDNF, Artemin,
CNTF, LIF, BDNF, and NGF (Jessen and Mirsky, 2008; Arthur-
Farraj et al., 2012). The recent identification of regulators of the
postinjury Schwann cell transformation has made it possible to
examine neuron survival and axon regeneration in the absence
of this transformation in vivo. A recent study accomplished this
by deleting c-jun, a master regulator of the Schwann cell
response to injury, specifically in Schwann cells. The authors
observed dramatic increases in neuronal death as well as de-
fects in axon regeneration, leading to the conclusion that injured
mature peripheral nerves depend on c-jun-driven changes in
Schwann cells in addition to autocrine signals for their survival
(Arthur-Farraj et al., 2012).In contrast to the high rates of neuronal survival in the injured
PNS, poor neuronal survival after CNS injury is amajor roadblock
to regeneration. Work to date suggests that CNS neuron loss
after injury results from a combination of loss of target-derived
trophic support, loss of trophic factor responsiveness, and insuf-
ficient glial-derived trophic support (Goldberg and Barres, 2000).
Although trophic factors are produced by astrocytes after injury
and astrocytes are sufficient to keep CNS neurons alive in
culture, these factors are not present in the combinations
and spatial and temporal gradients needed to support neuron
survival in vivo (Banker, 1980; Goldberg and Barres, 2000).
Glia and the Postinjury Extracellular Matrix: Inhibitory
Scar versus Growth-Promoting Channels
How Do PNS Glia Affect the Postinjury Extracellular
Matrix?
One of the major differences between the CNS and PNS is the
abundance of basal lamina. Schwann cells secrete a basal lam-
ina composed of growth-promoting laminin, type IV collagen,
and heparin sulfate proteoglycans (HSPGs), which is crucial to
the ability of these cells to myelinate (Bunge et al., 1990). Inter-
estingly, oligodendrocytes secrete no basal lamina, and, with
the exception of the pial surface and places where astrocytes
contact blood vessels, the healthy CNS is largely devoid of these
molecules (Cornbrooks et al., 1983). The abundance of basal
lamina surrounding Schwann cell-ensheathed axons in the
mature PNS and upregulation of proregenerative extracellular
matrix (ECM) molecules by Schwann cells after injury plays a
key role in PNS regeneration (Chen et al., 2007). Following
axon degeneration, persistent basal lamina forms tubes occu-
pied by proliferating Schwann cells aligned to create growth-
promoting channels known as bands of Bu¨ngner that guide
axon regeneration (Chen et al., 2007). When expression of
laminin is abolished by conditional deletion in Schwann cells,
peripheral axon regeneration is severely impaired (Chen and
Strickland, 2003). Consistent with an important role for laminins
in PNS regeneration, motor neurons upregulate integrins (laminin
receptors) on both their cell bodies and axons in response to
injury, and mice lacking these integrins exhibit reduced axon
outgrowth (Hammarberg et al., 2000; Werner et al., 2000). How
does integrin binding to laminin induce axon growth? Although
thismechanism is still being defined, the integrin-laminin interac-
tion is known to trigger PI3-kinase activation, Akt signaling, and
cytoskeletal rearrangements favoring axon growth, suggesting
that trophic factors and growth-promoting ECM molecules
may converge on common intracellular signaling pathways to
induce axon outgrowth (Chen et al., 2007).
How Do CNS Glia Affect the Postinjury ECM?
Some evidence suggests that, like Schwann cells, astrocytes
may upregulate growth-promoting ECM components such as
fibronectin and laminin after injury (Zamanian et al., 2012; Liesi
et al., 1983; Bernstein et al., 1985). However, these modest
proregenerative changes to the CNS ECM substrate are over-
shadowed by astrocyte upregulation of chondroitin sulfate pro-
teoglycans (CSPGs), a family of ECMmolecules highly inhibitory
to axon outgrowth. All proteoglycans consist of a protein core
and sulfated glycosaminoglycan (GAG) side chains. Of the
proteoglycans, the CSPGs are most well characterized for their
potent inhibition of axon outgrowth (McKeon et al., 1991).Developmental Cell 28, January 13, 2014 ª2014 Elsevier Inc. 9
Figure 1. The Axon Regeneration Equation
Whether or not an axon regenerates depends on
the balance of pro- and antiregenerative inputs to
the neuron. MAI, myelin-associated inhibitor;
CSPG, chondroitin sulfate proteoglycan. Dotted
lines indicate antiregenerative inputs.
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grecan, phosphacan, and NG2, all of which differ in terms of the
composition of their protein core and their number of GAG side
chains (Silver and Miller, 2004). With the possible exception of
NG2, it is the GAG side chains and not the protein core that
are inhibitory to axon outgrowth (Yiu and He, 2006). The stron-
gest evidence for the inhibitory mechanism of CSPGs comes
from in vivo experiments demonstrating enhanced axon
outgrowth and functional recovery in the presence of the chon-
droitin degrading enzyme, chondroitinase ABC, which selec-
tively degrades CSPG GAG side chains (Bradbury et al., 2002).
Interestingly, chondroitinase treatment appears not only to
enhance axon regeneration through regions of inhibitory ECM,
but also to promote collateral sprouting and new synapse forma-
tion, likely due to digestion of CSPGs present in perineuronal
nets around denervated targets (Massey et al., 2006; Alilain
et al., 2011).
CSPGs are used during development for boundary formation
at the optic tectum, spinal cord roof plate, and dorsal root entry
zones (Silver and Miller, 2004). Intriguingly, CSPG expression is
not upregulated in neonatal astrocytes after injury, and these as-
trocytes remain highly permissive to neonatal as well as adult
axon growth (Silver and Miller, 2004). While reactive astrocytosis
occurs throughout the distal stump of the injured CNS white-
matter tracts, high levels of CSPGs accumulate only within the
lesion core and penumbra and at distal sites of denervation (Fitch
and Silver, 2008). That CSPG upregulation is truly spatially
confined is demonstrated by studies by Davies et al. showing
that adult sensory neurons microtransplanted into the lesioned
spinal cord exhibit robust axon outgrowth over intact and degen-
erating CNS white-matter tracts but develop dystrophic growth
cones upon encountering the CSPGs at the site of injury and
denervated targets (Davies et al., 1997, 1999).
What is the mechanism of CSPG-mediated growth inhibition?
Evidence exists to support several general mechanisms,
including masking of neuronal integrin interactions with
growth-promoting ECM components such as laminin and
N-CAM, facilitation of the inhibitory effects of chemorepulsive
molecules such as Sema5a, limiting calcium availability to neu-
rons by binding extracellular calcium or its channels, and direct
interactions with functional CSPG receptors on the neuronal sur-
face (Sharma et al., 2012). Several CSPG receptors have been
reported in recent years, including LAR phosphatase, PTPs,
Ngr1, and Ngr3 (Fisher et al., 2011; Shen et al., 2009; Dicken-
desher et al., 2012). These receptors all interact specifically
with the GAG chains of CSPGs, and genetic deletion of these10 Developmental Cell 28, January 13, 2014 ª2014 Elsevier Inc.receptors in vivo results in enhanced
axon regeneration. The finding that mem-
bers of the Nogo Receptor family, initially
discovered for their interactions with
inhibitory myelin proteins Nogo, OMgP,and MAG, also mediate CSPG inhibition of axon outgrowth
reveals that two distinct classes of glial-derived extracellular
growth inhibitors produced by astrocytes and oligodendrocytes
converge on a common downstream signaling pathway. The
intracellular consequences of CSPG-mediated growth inhibition
are reported to involve several pathways, including RhoA activa-
tion, Akt inactivation, and calcium-related signals such as pro-
tein kinase C and transactivation of EGFR (Yiu and He, 2006).
Early studies revealed that PTPsigma activation leads to phos-
phorylation of neurotrophin receptors TrkB and TrkC, raising
the possibility that CSPG interaction with this receptor downre-
gulates neuronal responsiveness to trophic support (Faux
et al., 2007). Also of interest is recent evidence that, in addition
to CSPGs, the PTPsigma receptor also binds HSPGs, and the
two types of proteoglycans are competitive ligands for the re-
ceptor (Coles et al., 2011; Chien and Ryu, 2013). These findings
are consistent with reports that treatment with HSPGs can over-
comeCSPG inhibition at the glial scar and suggest that digestion
of CSPG GAG side chains using chondroitinase ABC may
promote regeneration not only by relieving CSPG inhibition but
also by enhancing growth promotion by HSPGs (Chien and
Ryu, 2013). Interestingly, integrin overexpression in CNS neu-
rons is also capable of overcoming CSPG inhibition, further
emphasizing the importance of considering the aggregate sum
of growth-promoting and growth-inhibitory inputs to injured neu-
rons rather than focusing on just one factor in the regeneration
equation (Figure 1; Tan et al., 2011).
Do Schwann cells express CSPGs as well? Schwann cells
do express CSPGs in the intact peripheral nerve and are even
reported to upregulate CSPG production after injury (Ho¨ke,
2006). The basal lamina tubes are hypothesized to play a crucial
role in shielding regenerating axons from CSPGs within
the endoneurium (Ho¨ke, 2006). In addition, the expression
of CSPG-degrading matrix metalloproteinases MMP-2 and
MMP-9 is upregulated in the distal stump of injured peripheral
nerves, which may contribute to relieving CSPG inhibition and
rendering the degenerating peripheral nerve more permissive
to axon regeneration (Ferguson and Muir, 2000; Heine et al.,
2004).
Glia and Myelin-Associated Axon Outgrowth Inhibitors:
Are CNS and PNS Myelin So Different After All?
Themyelin sheath is amodified and extended glial plasmamem-
brane formed by oligodendrocytes and myelinating Schwann
cells that spirals around the axon. In the healthy nervous system,
myelin benefits nerve function by increasing conduction speed
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components constitute the second major class of well-studied
nerve outgrowth inhibitors, along with CSPGs. Early in vivo ex-
periments demonstrated that a global reduction in spinal cord
and optic nerve myelination during development improves
regeneration and that peripheral immunization with myelin effec-
tively enhances corticospinal tract outgrowth within the vicinity
of the spinal cord lesion (Savio and Schwab, 1990; Keirstead
et al., 1992; Weibel et al., 1994; Huang et al., 1999). The major
inhibitory myelin components identified to date include myelin
proteins Nogo-A, myelin-associated glycoprotein (MAG), oligo-
dendroycte myelin glycoprotein (OMgP), myelin membrane-
bound chemorepulsive molecules semaphorin 4D and Ephrin
B3, and the myelin lipid sulfatide (Yiu and He, 2006; Winzeler
et al., 2011). Recent work has made great strides toward identi-
fying the mechanism of action of these inhibitors: their neuronal
receptors and downstream signaling intermediates. We now
know that Nogo-A, MAG, and OMgP all bind to the GPI-linked
Nogo Receptor (NgR), which uses coreceptors p75, TROY,
and LINGO1 for intracellular signal transduction (Yiu and He,
2006). The best-characterized downstream signaling pathway
of myelin inhibition is RhoA activation, and the mechanism of
myelin inhibition appears to be antagonized by cAMP/PKA
signaling (Giger et al., 2008).
Delivery of antibodies or blocking peptides specific to myelin
inhibitory molecules and their receptors improves axon regen-
eration and functional recovery (Schnell and Schwab, 1990;
Weibel et al., 1994; GrandPre´ et al., 2002). Despite these
mechanistic advances, however, transgenic mice lacking
known myelin inhibitory proteins or their receptors do not
consistently exhibit a robust CNS regeneration phenotype
(Yiu and He, 2006). These mixed findings point to the possible
existence of compensatory mechanisms and suggest yet-
undiscovered inhibitory interactions between myelin and
injured axons (Giger et al., 2008). Perhaps providing a partial
explanation for these results, an additional receptor, the paired
immunoglobulin receptor PirB, was recently discovered to be a
novel high-affinity receptor for Nogo, OMgP, and MAG, and
combined deletion of PirB and NgR achieved near-complete
release of axons from myelin inhibition in vitro (Atwal et al.,
2008). In addition, while NgR is a known receptor for the extra-
cellular domain of Nogo-A (Nogo-66), the receptor for Nogo-
A’s second inhibitory domain, amino-Nogo, has not yet been
reported. Finally, the evident complexity and redundancy of
CNS myelin-mediated axon outgrowth inhibition suggests
that the most effective therapeutic strategies will target not
the receptor-ligand interaction, but rather downstream intra-
cellular signaling within the neuron, where multiple pathways
of myelin inhibition converge.
Given the abundance of myelin throughout the PNS, how do
PNS axons overcome myelin inhibition? There are several
possible explanations to this question: PNS axons could be
less receptive or respond differently to inhibitory myelin cues,
PNS myelin could be inherently less inhibitory than CNS myelin,
or myelin could be cleared more effectively from the injured PNS
than from the injured CNS. Failure of PNS axons to extend axons
on a CNS myelin substrate in vitro and into an acellular optic
nerve graft suggests that PNS axons can indeed respond to
inhibitory myelin cues (Schwab and Thoenen, 1985; Schwaband Caroni, 1988). Further supporting this argument, overex-
pression of Nogo-A in Schwann cells causes a delay in PNS
axon regeneration (Pot et al., 2002). However, of the known
inhibitory myelin components, the one most abundant in PNS
myelin, MAG, is known to be able to function as both a
growth-inhibitory and growth-promoting molecule, depending
on cAMP levels in the regenerating axon, raising the possibility
that changes in the intrinsic state of PNS neurons after injury
allow them to undergo a switch in their responsiveness to the
predominant PNS myelin-derived inhibitor (Cai et al., 2002).
In terms of myelin composition, whether or not PNS myelin is
less inhibitory to axon outgrowth than CNS myelin remains
controversial. Compared to typical plasma membrane, myelin
has a higher lipid content and a lower protein content. Qualita-
tively, the lipid content of CNS and PNS myelin is similar, but
the relative amounts of different components differ. PNS myelin
has less sulfatide and cerebroside and more sphingomyelin than
CNS myelin. In terms of major myelin proteins, CNS and PNS
myelin both contain large quantities of myelin basic protein
(MBP). CNS myelin is also rich in PLP, which is found in much
lower quantities in PNS myelin in exchange for myelin protein
zero (P0) and peripheral myelin protein 22 (PMP22) (Quarles
et al., 2005). A specific look at the myelin proteins known to
play a major role in axon outgrowth inhibition reveals that
MAG, present on the axonal surface of the myelin sheath, is pre-
sent in both PNS andCNSmyelin, but the others are restricted to
CNS myelin (Quarles et al., 2005). These data suggest that PNS
myelin might be less inhibitory to axon outgrowth than CNS
myelin. Indeed, in vitro studies indicate that sensory axons
extend over much greater distances on a PNS myelin substrate
than on CNSmyelin (Schwab and Caroni, 1988). Additional work
demonstrates that PNS neurons cultured in the presence of
NGF can extend axons robustly through acellular sciatic nerve
explants, but not into acellular optic nerve explant bridges
(Schwab and Thoenen, 1985). However, this study does not
dissect out the contribution of the growth-promoting ECM sub-
strate of the sciatic nerve explant from the effects of PNSmyelin,
leaving the possibility that inhibition by PNS myelin is simply be-
ing counteracted by the growth-promoting PNS ECM. In support
of the concept that PNS myelin is at least somewhat inhibitory,
You et al. revealed that optic nerve regeneration into a peripheral
nerve graft is greatly enhanced when the peripheral nerve is first
allowed to undergo a period of predegeneration, during which
myelin is degraded and cleared (You et al., 2002). What percent-
age of the proregenerative effects in this case are due to myelin
clearance versus increased Schwann cell production of trophic
factors and growth-promoting ECM components, however, is
not clear. Finally, several studies provide evidence that delaying
myelin clearance in the injured peripheral nerve also delays
PNS regeneration, suggesting that PNS myelin does have an
inhibitory effect on axon outgrowth and that its clearance is a
prerequisite for timely regeneration (Brown et al., 1994; Dailey
et al., 1998; Vargas et al., 2010). In summary, while it remains
possible that PNSmyelin is a less-potent inhibitor of axon regen-
eration than its CNS counterpart, there is sufficient evidence
demonstrating that PNS axons are competent to respond to
myelin-associated outgrowth inhibitors and that clearance of
PNS myelin is an important component of successful PNS
regeneration.Developmental Cell 28, January 13, 2014 ª2014 Elsevier Inc. 11
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Figure 2. Schematic Depiction of the PNS after Axon Injury
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Figure 3. Schematic Depiction of the CNS after Axon Injury
Developmental Cell
ReviewGlia andMyelin Debris Clearance after Injury: Activating
Phagocytosis or Not
Regardless of whether one type of myelin is more inhibitory than
the other, one of the major differences between the CNS and
PNS responses to injury is the regulation of myelin protein
expression and the rate of myelin debris clearance. In the injured
mammalian PNS, myelin debris is cleared effectively within 2 to
3 weeks of injury (Figure 2), while in the CNS (Figure 3), myelin
debris can still be found littering degenerated tracts months to
even years after injury (George and Griffin, 1994; Miklossy and
Van der Loos, 1991; Becerra et al., 1995; Buss et al., 2004). In
addition, Schwann cells robustly downregulate myelin proteins
after injury, while transient upregulation is reported in oligoden-
drocytes (Bartholdi and Schwab, 1998; Jessen and Mirsky,
2008). Given the inhibitory properties of myelin, strategies to
enhance its clearance from degenerating CNS tracts have
exciting therapeutic potential.
How Is Myelin Cleared So Efficiently in the PNS?
Schwann cells carry out the initial phase of myelin clearance and
are the primary phagocytic cells in the injured peripheral nerve
for the first 5 days after injury (Liu et al., 1995; Perry et al.,
1995; Gaudet et al., 2011). Schwann cells are subsequently
aided by hematogenous macrophages, which enter the basal
lamina tubes and contribute to myelin clearance using IgG-
and complement-dependent mechanisms (Dailey et al., 1998;
Vargas et al., 2010). Although well understood, the macrophage
mechanism of myelin clearance has thus far been difficult to
translate to the injured CNS. One major reason for this impasse
is that infiltration of macrophages and blood-barrier breakdown
in the injured CNS is restricted to the immediate vicinity of
the CNS lesion, meaning that macrophages and the opsonins
on which they depend for phagocytosis may not gain sufficient
access to the distal degenerating axons (Vargas and Barres,
2007; Popovich andHickey, 2001).Microglia, the residentmono-
cyte-derived cells in the brain, express a broad repertoire of
phagocytic receptors. The abundance of microglia throughout
the injured CNS makes these cells promising candidates for
performing myelin clearance within the CNS, similar to macro-
phages in the PNS. Why microglia do not exhibit robust
clearance of myelin after CNS injury is not fully understood
(Rotshenker, 2003; Ransohoff and Brown, 2012). The continued
advent of new tools for the study of these cells will make this an
interesting avenue for study in the near future.
Surprisingly, despite recent insights into the Schwann cell
response to injury, the mechanism that drives Schwann cell12 Developmental Cell 28, January 13, 2014 ª2014 Elsevier Inc.phagocytosis of myelin debris is far from understood, although
galectin-3 has been suggested to play an important role (Reich-
ert et al., 1994). One crucial component of this mechanismmight
be the initiation of myelin breakdown by Phospholipase A2
(PLA2), which is expressed in intracellular and secreted forms
by Schwann cells as early as 5 hr after sciatic nerve crush injury.
The hydrolysis by PLA2 of phosphotidylcholine, which is en-
riched in myelin membranes, results in the production of lyso-
phosphotidylcholine (LPC), an agent that has potent myelinolytic
activity (Martini et al., 2008). If intracellular PLA2s are blocked,
many intact compact myelin profiles remain preserved as late
as 7 days after injury, suggesting a role for these phospholipases
in initiating myelin breakdown. Intriguingly, PLA is upregulated
only very late (8 weeks after injury) in the injured optic nerve (Mar-
tini et al., 2008). Uncovering the mechanism of myelin clearance
by Schwann cells is a key missing piece in our understanding of
peripheral nerve biology and has the potential to shed light on
strategies for activating myelin clearance in the CNS. Under-
standing more about the biochemistry of myelin degradation
and how this process differs between the CNS and the PNS
will also be an important step toward this goal.
If Schwann Cells Perform Myelin Clearance in the PNS,
Why Don’t CNS Glia Clear Myelin after Axon Injury?
A recent microarray study compared the phagocytic machinery
expressed by astrocytes and oligodendrocytes in the healthy
CNS (Cahoy et al., 2008). The results indicated that oligodendro-
cytes expressed only very low levels of phagocytic pathways.
This finding combined with oligodendrocyte susceptibility to
apoptosis after CNS injury is consistent with evidence that oligo-
dendrocytes make only a very small contribution to myelin
uptake. Surprisingly, however, analysis of astrocytes in the
same study revealed that these cells express very high levels
of several phagocytic receptors and their downstream pathway
components, suggesting that astrocytes have a much greater
phagocytic capacity than formerly believed.
Why astrocytes do not participate more in CNS myelin clear-
ance despite robust expression of phagocytic machinery is an
intriguing mystery. One possibility is that reactive astrocytes
downregulate their phagocytic pathways. Another possibility is
that CNS myelin may be resistant to phagocytosis by failing to
express the correct ‘‘eat me’’ signals or displaying persistent
‘‘don’t eat me’’ signals to phagocytes. Further work is needed
to determine which of these scenarios describes stalled
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mulating evidence points to a role for myelin debris in inhibiting
remyelination, as well as to a link between persistent cellular
debris and susceptibility to autoimmunity (Kotter et al., 2006;
Lleo et al., 2008). Therefore, as the focus of the axon regene-
ration field progresses from long-distance axon growth to
long-term functional recovery, achieving myelin clearance will
continue to be an important consideration.
Glia and Postinjury Inflammation: Interfacing with the
Immune Response
How Do Schwann Cells Interface with the Peripheral
Nerve Immune Response?
Asmentioned previously, hematogenousmacrophagesmake an
important contribution to myelin clearance after peripheral nerve
injury. Macrophages enter the nerve in large numbers due to
breakdown of the blood-nerve barrier throughout the distal nerve
and active recruitment of these cells into the nerve by serum
factors and chemokines (Vargas et al., 2010). Schwann cells co-
ordinate recruitment ofmacrophages into the peripheral nerve by
upregulating secretion of chemokines, including TNF-a, LIF, Il-1a
and Il-1b, Il-6, and MCP-1, after injury (Gaudet et al., 2011). The
fatty acids released during peripheral myelin breakdown also
modulate the inflammatory response through production of pros-
taglandins and leukotrienes that trigger immune cell infiltration
into the damaged nerve tissue (Martini et al., 2008). Just as
they are crucial to inflammatory cell recruitment, Schwann cells
also play a key role in terminating the inflammatory response to
PNS injury. Recent studies indicate that macrophage phagocy-
tosis of myelin, like that of apoptotic cells, stimulates an anti-
inflammatory macrophage phenotype (Voll et al., 1997; Boven
et al., 2006). In addition, Schwann cell remyelination of regener-
ated tracts is reported to stimulate macrophage efflux from
Schwann cell basal lamina tubes through interactions between
macrophage NgR and MAG on the myelin membrane (David
et al., 2008; Fry et al., 2007).
Do Glia Also Recruit Macrophages into the Injured CNS?
As mentioned above, hematogenous macrophage entry into the
injured CNS is limited to the site of injury due to restricted blood-
brain-barrier breakdown (Vargas et al., 2010). The macrophage
influx that does occur happens on a protracted time course in
comparison with the PNS. Accordingly, there is currently little
evidence for the entry of large numbers of peripheral macro-
phages into the brain parenchyma duringWallerian degeneration
of injured CNS tracts (Vargas et al., 2010). Although they do not
successfully recruit macrophages into the injured CNS, astro-
cytes are a primary source of innate inflammatory mediators af-
ter CNS injury and secrete components of the complement
pathway in addition to IL-1b, IL-6, and chemokines such as
CCL2, CXCL1, CXCL10, and CXCL12 (Ransohoff and Brown,
2012). Some aspects of the astrocyte inflammatory response
to injury act to dysregulate astrocyte homeostatic function,
potentially worsening outcomes. For instance, CXCL12 released
by astrocytes promotes physiological release of glutamate dur-
ing synaptic transmission as well as release of small amounts
of TNF-a, which, together with CXCL12, act to trigger release
of large quantities of TNF-a from microglia (Ransohoff and
Brown, 2012). In the presence of high concentrations of TNF-a,
astrocyte capacity to detoxify glutamate is impaired, resultingin excitotoxicity-mediated neuronal loss. Astrocytes also release
anti-inflammatory IL-10, however, and the STAT-3 pathway of
reactive gliosis appears to inhibit microglial release of TGF-b,
improving maturation of oligodendrocyte precursor cells after
injury (Nobuta et al., 2012; Ransohoff and Brown, 2012). Future
work on astrocyte-microglia interactions will yield much-needed
insight into CNS innate immunity.
Concluding Remarks
Work over the past several years hasmade numerous solid steps
forward toward understanding the glial response to nerve injury.
Several issues arise out of the current picture.
Should We Be Trying to Inhibit Reactive Gliosis?
Is reactive gliosis good or bad? The long-standing debate over
whether reactiveastrocytesareharmful or beneficial to the injured
CNS is still ongoing. Pioneering work by Sofroniew and col-
leagueshasprovidedawindow into the injuredCNSwithout reac-
tive astrocytes through the construction of a mouse in which pro-
liferative, GFAP-expressing astrocytes are deleted (Bush et al.,
1999;Sofroniew,2009). These studiesconfirm that reactiveastro-
cytes are at the same time beneficial and deleterious to the post-
injury CNS. On the one hand, they secrete growth-inhibiting
CSPGs, produce proinflammatory cytokines, and induce excito-
toxicity, whereas on the other hand they demarcate damaged
tissue, restrict inflammation, protect neuron and oligodendrocyte
survival by inhibiting microglial release of inflammatory media-
tors, stimulate blood-brain-barrier repair, and counteract edema
(Sofroniew, 2009). The complexity of the astrocyte response
raises two questions. First, are all reactive astrocytes performing
all of these functions, or are theresubsetsof astrocytesanalogous
to M1 and M2 populations of macrophages that could be selec-
tively targeted therapeutically? There is already compelling
evidence for heterogeneity in the astrocyte response across
different CNS regions (Hill et al., 1996; Waselle et al., 2009;White
et al., 2010). Whether heterogeneity exists within astrocyte
populations will be an exciting area of future study.
Second, what are the signaling pathways underlying these
diverse functions of reactive astrocytes, and can we selectively
inhibit certain ones to favor certain functions over others? Evi-
dence from a recent comparative microarray analysis of reactive
astrocytes following ischemic and LPS-induced injury demon-
strates that different insults lead to significant variations in the
astrocyte reactive phenotype (Zamanian et al., 2012). One of
the major barriers to studying reactive gliosis is that the molecu-
lar triggers of this process are not well defined. A model of
reactive gliosis in which one can add and subtract from a list of
ingredients sufficient to recapitulate the reactive state would
be invaluable to projects aimed at uncovering the upstream
signaling that converges on reactive gliosis. The Sofroniew lab-
oratory has made an important step in this direction by devising
methods using Cre-lox technology for investigating the role of
specific signaling pathways, including STAT3 (Sofroniew, 2005;
Wanner et al., 2013). Studies using this approach and others
will provide much-needed insight into ways to dissect desired
from undesired aspects of this postinjury phenomenon.
Is Glial Dedifferentiation the Desired Postinjury
Outcome?
Development provides a rich source of information on the
intrinsic and extrinsic conditions that facilitate axonal outgrowth.Developmental Cell 28, January 13, 2014 ª2014 Elsevier Inc. 13
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enumerated in the introduction to this Review are highly reminis-
cent of the neuron early in development, and devising strategies
to recapitulate aspects of development has been a fruitful
approach to tackling CNS regeneration failure.
Immature CNS glia are reported to guide axons across major
interhemispheric commisures within the developing brain, and
we discussed earlier that when neonatal astrocytes become
reactive after injury, they fail to secrete growth-inhibiting CSPGs
(Silver and Miller, 2004; Silver et al., 1982). Should dedifferentia-
tion of astrocytes, then, be a therapeutic goal after brain and spi-
nal cord injury, or would these immature cells lack the ability to
perform the beneficial aspects of reactive astrocytes, such as
counteracting brain swelling and isolating the area of injury? In
terms of oligodendrocytes, an important question is how closely
the process of remyelination recapitulates developmental myeli-
nation. Several studies now provide evidence for recapitulation
of developmental mechanisms during remyelination, but other
work reveals differences between myelination during develop-
ment and nerve repair, likely due to variations in axon-derived
signals or the inflammatory milieu (Fancy et al., 2011). Under-
standing key differences between these two processes will be
paramount in optimizing the success of remyelination by newly
generated OPCs and those already resident in the adult brain.
Until recently, the Schwann cell response to PNS axon injury
was referred to as a process of dedifferentiation during which
these cells assumed the gene expression and phenotype of
immature, premyelinating Schwann cells. Important work in the
past 2 years, however, has revealed that the postinjury Schwann
cell is in fact a unique ‘‘repair cell’’ that results from a process of
transdifferentiation rather than dedifferentiation (Arthur-Farraj
et al., 2012). In fact, in the developing PNS, Schwann cells do
not guide axons to their targets at all. Instead, Schwann cells
populate the nerve after the axons and are guided by the axons
to their final destinations (Jessen and Mirsky, 2005), corrobo-
rating the notion that dedifferentiation of Schwann cells is not
necessarily the desired postinjury outcome.
Finally, while invaluable clues about regeneration can be
gleaned from studying axon growth during development, some
evidence suggests that axon regeneration may be mechanisti-
cally distinct. For example, during development, growth cone
extension is dependent on F-actin-mediated filopodial out-
growth, while extension of regenerating axons appears to rely
instead on protrusive forces generated by microtubules (Jones
et al., 2006; Jin et al., 2009). The possibility that the mechanism
of axon outgrowth differs between development- and injury-
induced regeneration further underscores the question of
whether reverting the glial environment to a more develop-
ment-like state should be a central objective in nervous system
repair.
Appreciating Neuronal and Glial Heterogeneity
It is becoming increasingly appreciated that there is impressive
heterogeneity in the capacity of different white-matter tracts to
regenerate in response to various therapeutic manipulations
and that these different outcomes can be explained by differ-
ences in both neurons and glia. Although all known intrinsic
and extrinsic mechanisms of growth promotion and inhibition
are important pieces to the CNS regeneration puzzle, depending
on the specific region of the CNS in question, certain aspects of14 Developmental Cell 28, January 13, 2014 ª2014 Elsevier Inc.this puzzle emerge as more or less important. For instance, in
tracts with axons expressing only relatively low levels of NgR,
neutralizing myelin inhibitors is likely to be of less concern than
neutralizing CSPGs (Alilain et al., 2011). Observations that
certain types of tracts possess an enhanced capacity for regen-
eration also presents an opportunity for the discovery of novel
pro- and antigrowth components of the axon regeneration equa-
tion (Cheng and Olson, 1995).
In terms of heterogeneity within CNS and PNS glial popula-
tions, we now know that Schwann cells express distinct sensory
andmotor phenotypes and that these cells preferentially support
the regeneration of neurons of matching modality (Ho¨ke et al.,
2006). Recent work on early stages of CNS development reveals
that unique subsets of CNS glia are derived from temporally and
regionally distinct precursor populations (Rowitch and Krieg-
stein, 2010). As mentioned above, some regional variation in
the astrocyte response to injury has already been reported.
Further investigation of subpopulations of glia in the context of
axon regeneration presents exciting avenues for future work.
In conclusion, while the ultimate outcome of CNSwhite-matter
injury depends on the axon’s capacity for regeneration, the abil-
ity to probe this capacity and to target it therapeutically is wholly
dependent on an understanding of the glia in the axon’s environ-
ment and their complex response to axon insult. Comparing the
postinjury phenotype of PNS and CNS glia reveals several major
ways in which these cells differ in their injury response. These
differences highlight opportunities to gain a deeper understand-
ing of the mechanisms employed by PNS glia postinjury and to
devise powerful strategies for translating these mechanisms to
the injured CNS.
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